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Summary 
Commitment o fT  helper 1 (Thl) or Th2 populations developing during an immune response 
to a pathogen, or an inappropriate immune response to an allergen or autoantigen, may deter- 
mine the difference between health and chronic disease. We show that strongly polarized Thl  
and Th2 populations assessed by immunoassay re heterogeneous sing flow cytometry to de- 
tect single cells producing interferon */(IFN-~/) and interleukin 4 (IL-4). Thl  populations aris- 
ing after 1 wk of stimulation in IL-12 plus anti-IL-4 antibodies could convert o Th2 cells 
when restimulated in IL-4. Th2 populations resulting from stimulation for 1 wk in IL-4 could 
give rise to Thl  cells upon restimulation i IL-12 plus anti-IL-4. In contrast, he cytokine pro- 
files of long-term Thl and Th2 populations arising originally from repeated stimulation in 
IL-12 or IL-4 appeared more homogeneous and were not reversible, although IL-4 dramati- 
cally reduced the number of IFN-'?--producing Thl  cells. This may explain previous reports 
that Thl  cells can be converted to Th2 cells. 
D evelopment of the appropriate CD4 + Th subset dur- ing an immune response is critical for eradication of 
infectious organisms (1-3). These subsets of Th cells may 
be distinguished by the pattern of cytokines that they pro- 
duce. Thl  cells produce IFN-~/and lymphotoxin and play 
a critical role in directing cell-mediated immune responses, 
important for the clearance of intracellular pathogens. Th2 
cells producing IL-4, -5, -10, and -13, have been associated 
with allergy and are important for humoral responses (1--6). 
An important role for Th2-type cytokines, such as IL-4 and 
IL-10, is their abihty to regulate Thl  responses (7-11) 
which are important for the clearance of infectious organ- 
isms but may also result in pathology if ehcited against self- 
antigens (12-14). 
Cytokines present during the initiation ofa CD4 + T cell 
response can determine the development ofa particular Th 
cell phenotype (10, 15-19). Th2 cells develop when naive 
T cells are stimulated in vitro in the presence of IL-4 (10, 
15, 17). In addition, the presence of IL-4 during priming 
has also been shown to play an important role in vivo, for 
example, in establishing a Th2 nonhealing response in 
BALB/c mice to the intracellular parasite Leishmania major 
(20, 21). Conversely, IL-12 is a critical factor driving the 
development of Thl  cells from antigen-specific naive 
CD4 + T cells (16, 18, 19); in addition, it enhances IFN-~/ 
production by Thl  clones (22) and human Th2/Th0-type 
clones and activated Th cells (23, 24). Despite the induc- 
tion of IFN-~/production by seemingly committed human 
Th2/Th0 clones (23), such polarizing stimuli as IL-4 or 
IL-12 have been found to be most effective when delivered 
at the initiation of the immune response, both in vitro (10, 
15-19) and in vivo (20, 21, 25-27). 
P, ecendy, ongoing Th2 responses to L. major were found 
to be reverted to a heating Thl  response when BALB/c 
mice were treated uring chronic infection with Pentostam 
(to reduce the parasite infection) together with IL-12 (28), 
or by transferring the Th2 populations to scid mice under 
appropriate conditions (29, 30). In addition, polarized Thl  
populations obtained from mice infected with L. major 
have been modified to produce Th2-type cytokines by re- 
culture in vitro with specific antigen, APCs, IL-2, and IL-4 
(31). These data are reminiscent of studies in human sys- 
tems that demonstrated that purified protein derivative- 
specific T cells which normally outgrow with a Thl-like 
profile, can be selected as Th2-1ike if IL-4 is added early in 
bulk cultures (32). In contrast o the in vivo studies dis- 
cussed above showing the reversal of a Th2 phenotype, re- 
cendy it has been shown that although the phenotype of 
early Thl  cells was efficiently reversed in vitro by addition 
of IL-4, Th2 cells were resistant to phenotype reversal (33, 
34). Although in some cases, these studies involve T cell 
populations that are clonal with respect to their antigen re- 
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ceptor, they undoubtedly all deal with heterogeneous pop- 
ulations of  Th cells with respect o cytokine production 
(35), and the level of  commitment for cytokine production 
at the single cell level is unclear. To address this, and to ob- 
tain information on whether a switch in Th phenotype re- 
flects a true conversion or the suppression of  the polarized 
phenotype by outgrowth and/or  differentiation of  uncom- 
mitted precursors, we have employed flow cytometry to 
detect single cells producing IFN-~ and IL-4 (35). Using 
this technology we assessed the plasticity of  seemingly po- 
larized Th l  and Th2 populations in an in vitro system us- 
ing CD4 + T cells from TCR-transgenic mice (10, 36), re- 
stimulated with antigen under conditions designed to 
reverse their pattern of cytokine production. 
Materials and Methods 
Animals. Mice transgenic for the D011.10 TCR-~/[3 on a 
BALB/c genetic background (36) were identified at age 4-6 wk by 
staining peripheral b ood leukocytes with the anti-TCR clonotype- 
specific mAb KJ1-26 (37, 38). All transgenic mice used were het- 
erozygous for the TCR 0t and [3 transgenes. Female nontrans- 
genic BALB/c mice between 6 and 10 wk old were purchased 
from Simonsen Labs (Gilroy, CA). 
Th Cell Clones. Stimulation and maintenance oflong-term Th 
clones was as previously described: Thl, HDKI (BALB/c-derived, 
KLH specific, I-A a restricted; 39) and Th2, CDC25 (C3D2/F1/ 
J-derived, normal rabbit IgG specific, H-2I d restricted; 40). Short- 
term Th clones derived from unimmunized DOl1.10 TCR-a/[3 
transgenic mice were obtained by sorting single cells on the basis 
of CD4 +, leukocyte ndothelial cell adhesion molecule (LECAM) ~ 
lbn~ t, KJ1-26 + into 96-well microtiter wells containing 105 irra- 
diated splenic APCs (3,000 rad) plus OVA (0.3 IxM) under the 
following conditions: Thl clones, in the presence oflL-2 (10 v U/  
mg, 330 U/n'd), IL-12 (106 U/mg, 100 U/ml; plus small amounts 
of 1L-4, which were required to maintain cell viability), plus 
TGF-[3 (2 ng/ml); Th2 clones, in the presence oflL-2 (330 U/ml) 
and large amounts of IL-4 (107 U/mg, 100 U/ml); and Th0 
clones, in the presence of IL-2 (330 U/n-d), IL-4 (15 U/ml), and 
IL-12 (10 U/ml). All the DO11.10-derived clones were 100% 
positive for the clonotype antibody, KJ1-26 (cells are referred to 
as clones when they have been derived from a single cell in cul- 
ture, as opposed to populations described below, which although 
carrying the same transgene and thus antigen specificity, were not 
derived from single cells in culture). Clones were restimulated 
and expanded under the respective conditions every 2 wk. All 
clones were expanded and maintained in RPMI 1640 (JR Scien- 
tific Inc., Woodland, CA) containing 10% FCS (JR Scientific 
Inc.), t-glutamine (2 raM), penicillin (100 U/n-d), streptomycin 
(100 Ixg/m/), Hepes buffer (10 raM), sodium pyruvate (1 mM), 
2-mercaptoethanol (0.05 raM, Sigma Chemical Co., St. Louis, 
MO), (complete RPMI), supplemented with mouse rlL-2 (330 
U/tul), and the respective initiating conditions were used for 
growth of the clones. In some cases, clones were stored in liquid 
nitrogen and cells were thawed into medium containing murine 
rlL-2 (330 U/m/), as above, 5-7 d before assay. 
Rested T cell clones were washed, counted, and resuspended 
1Abbreviation used in this paper: LECAM, leukocyte ndothelial cell adhe- 
sion molecule. 
at 2 • 10S/well. They were restimulated with irradiated (3,000 
rad) splenic APCs plus specific antigen or PMA (50 ng/ml) plus 
ionomycin (500 ng/ml) for 4 h at 37~ with Brefeldin A (10 
bLg/ml; Epicentre Technologies, Madison, WI) added for the last 
2 h, for flow cytometric analysis ofintracellular cytokine staining. 
Identical stimulations of T cells were set up in parallel but in the 
absence of Brefeldin A, for 48 h at 37~ for analysis of IL-4 and 
IFN-"/ in supernatants by immunoassay as previously described 
(41-43). 
Culture Medium, Cytokines, Antibodies and Antigens, and other Re- 
agents. Cell cultures were maintained in cRPMI as described 
above, but usually without supplemented cytokines, unless indi- 
cated. 
Recombinant mouse cytokines were obtained from the fol- 
lowing sources: IFN-'y (Schering Research, Bloomfield, NJ), IL-4 
(Dr. S. Menon, DNAX Research Institute), TGF-[3 (R&D Sys- 
tems, Inc., Minneapolis, MN), and IL-2 (a kind gift from Gerard 
Zurawski, DNAX Research Institute). Recombinant mouse IL-12 
was obtained by transfecting COS7 cells with the cDNA encod- 
ing the p35 and p40 cDNA as described previously (44), which 
was obtained by PCR cloning using published sequences (44). 
Supernatants from mock-transfected cells were used as a control 
and showed no effect in the concentration range at which IL-12 
was used. The IL-12 content of the supernatants ranged from 
2,000 to 10,000 U/ml (22). 
Purified rat anti-mouse IL-4 (11B11) and anti-IFN-',/ (AN18) 
antibodies previously described (42, 45), and an isotype-matched 
control were supplied by J. Abrams (42; DNAX Research Insti- 
tute), mAbs used for flow cytometric sorting or analysis included 
anti-mouse CD4-PE and LECAM-1-FITC (both from Phar- 
Mingen, San Diego, CA). Additional anticytokine mAbs for im- 
munoassay and flow cytometry, induding anti-mouse IL-4 and 
IFN-y reagents, were purified from serum-free hybridoma super- 
natants as previously decribed (42). 
The antigenic OVA-peptide (0VA323_339) from chicken OVA 
was synthesized on a peptide synthesizer (model 430; Applied 
Biosystems, Lewisville, TX). 100 Ixg/ml KLH and 500 txg/ml 
rabbit IgG (Sigma Chemical Co.) were used. 
Preparation of T Cells and APCs. CD4 + T cells were enriched 
by negative selection using Magnetic Activated Cell Sorting 
(MACS) with a cocktail ofbiotinylated anti-mouse CD8e~, I-A d, 
B220, and Mac-1 antibodies as previously described (35) (Mil- 
tenyi, Sunnyvale, CA). T cells staining positive for CD4 and 
LECAM-1 were further purified by positive selection using a 
FACStar Plu~| flow cytometer (Becton Dickinson & Co., San Jose, 
CA) to achieve 99.8% CD4 + T cells. Staining did not alter the 
function of the T cells (not shown). 
Stimulation of Transgenic CD4 + T Cells for Cytokine Production. 
Primary stimulations of CD4 + T cells (2.5 • 10S/well) were car- 
fled out using OVA peptide (0.3 IxM) and nucleated spleen cells 
(5 • 106/well, 3,000 rad) as APCs in a total volume of 2 ml in 
24-well plates. In addition, some cultures received cytokines ([IL-4 
(200 U/ml)] or IL-12 [10 U/ml]) or mAbs to block endogenous 
cytokines (anti-IL 4 [10 I.tg/ml]). T cells were expanded and 
maintained in the same culture conditions for 1 wk. Cells were 
then harvested on day 6, washed three times, counted, and a por- 
tion of them resnspended at 2 • 105/well, and restimulated with 
PMA (50 ng/ml) plus ionomycin (500 ng/ml) for 4 h at 37~ 
with Brefeldin A (10 I~g/ml) added for the last 2 h (to enhance 
flow cytometric analysis ofintracellular cytokine staining). The cells 
were then ftxed and and stained for detection of intracellular cy- 
tokine synthesis as described below. Identical stimulations ofT cells 
were set up in parallel but in the absence of Brefeldin A, for 48 h 
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at 37~ for analysis of IL-4 and IFN-~/in supematants byimmu- 
noassay as described below. 
Additionally, naive CD4 + T cells were stimulated in primary 
cultures, under the same conditions as above, but in this case the 
stimulations were repeated weekly for three consecutive weeks 
(chronic stimulation) before washing, harvesting, restimulating, and 
analyzing as above. 
For phenotype reversal studies, cultures of Th cells developed 
from naive CD4 + T cells were stimulated under the above condi- 
tions either once or repeatedly for three consecutive weeks. Cells 
were washed and then recultured under the same conditions with 
APCs and antigen alone, or in the presence of the same polarizing 
stimulus, or an oppositely polarizing stimulus (IL-4 or IL-12 plus 
neutralizing anti-IL-4 antibodies), for I wk or repeatedly for three 
consecutive weeks. The cells propagated under all the different con- 
ditions and time points were 100% CD4 +, KJ1.26 +. Cells were 
then washed, harvested, and restimulated before analyzing as above. 
Cytokine Assays. IFN-7 was detected using a two-site sand- 
wich ELISA (41, 42, 46) which has a lower limit of sensitivity of 
125 pg/ml (1 U/ml or 100 pg/ml). The ELISA for IL-4 has been 
described previously (41, 42) with a lower limit of sensitivity of 
100 pg/ml. 
Flow Cytometric Analysis of Intracellular IFN-T and IL-4 Synthesis. 
Cells were resuspended at 105-106/ml and stimulated with PMA 
at 50 ng/ml plus ionomycin at 500 ng/ml. 2 h before cell harvest, 
Brefeldin A was added at 10 p,g/ml, using a stock of I mg/ml in 
ethanol (100%). Cells were harvested, washed, and resuspended 
in PBS with Brefeldin A before adding an equal volume of 4% 
formaldehyde fixative (final concentration 2%). After fixing for 20 
min at room temperature, cells were either stored at 4~ for up to 
2 d, or stained immediately for cytokines using a modified method 
(35) based on that described by Assenmacher tal. (47) and others 
(48, 49). For intracellular staining, all reagents and washes con- 
tained 1% BSA and 0.5% saponin (Sigma Chemical Co.), and all 
incubations were at room temperature. Cells were washed and 
preincubated for 10 rain in PBS/BSA/saponin, and incubated 
with anti-IL-4 (11Bll) at 5 b~g/ml or isotype-matched control 
GLl13 (isotype control) at 10 p,g/ml for 30 rain. After two washes 
and blocking with rabbit serum/0.5% saponin, optimal concentra- 
tions of FITC anti-rat Ig (antibody raised in rabbit; Vector Labo- 
ratories, Inc., Burlingame, CA) were added for 30 min. After two 
washes, purified rat Ig was added at 300 btg/rnl for 10 rain to 
block residual anti-rat Ig binding. Without washing, anti-IFN-~/ 
(AN18-PE) (or control PE-conjugated rat Ig, Pharmacia, Piscat- 
away, NJ) was added at a 2.5-p,g/ml final concentration. After 20 
min, cells were washed twice with PBS/BSA/saponin and then 
with PBS/BSA without saponin to allow membrane closure. 
Cells were then stained with the clonotypic antibody KJ1.26 (36) 
to confirm the presence of 100% OVA-specific TCR-transgenic 
CD4 + T cells. Data are displayed as bivariate dot plots. Samples 
were analysed on a FACScan | flow cytometer (Becton Dickinson 
& Co.). Thresholds were set on control stains (included for every 
sample at every time point) to lie on the first percentile (not 
shown) as previously described (35). Our previous tudy confirms 
the specificity of detection of intracellular cytokine synthesis by 
this method (35). Results were analyzed using Lysis II and 
Cellquest software. 
Results and Discussion 
Reversal of the Cytokine Profile of Th I or Th2 Populations 
Generated by Stimulation for 1 wk in the Presence of Polarizing 
Stimuli. We have previously demonstrated that naive CD4 + 
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T cells from the DOl1 .10 OVA-specific TCR-~x/[3 trans- 
genic mouse can be induced to develop into either Th l  or 
Th2 populations, when stimulated for 1 wk with specific 
antigen and APCs in the presence of IL-12 or IL-4, respec- 
tively (10, 16, 35, 36). Although, these Th populations ap- 
peared to be completely polarized as assessed by levels of  
IFN-~/or IL-4 detected in the supematants by immunoas- 
say after T cell activation (10, 16, and Figs. 1 A and 2 C), 
the composition of  the population with respect o cytokine 
production by single cells, or their level of  commitment to a 
particular cytokine profile, was unclear. Using flow cytom- 
etry to detect single cells producing IFN-~/and IL-4 (35), 
we assessed the possible heterogeneity and plasticity of  these 
polarized Thl  and Th2 populations when restimulated with 
antigen under conditions designed to reverse their pattern 
of  cytokine production (Figs. 1 and 2). To produce polar- 
ized Th cell populations, naive CD4 +, LECAM-1 b~ght, T
cells from DOl l .  10 TCR-et/[3-transgenic mice were stim- 
ulated with OVA and irradiated splenic APCs for 1 wk, in 
the presence of either IL-4 to produce Th2 populations, or 
IL-12 (plus or minus anti-IL-4 mAb) to produce Thl  pop- 
ulations (10, 16). 
Naive CD4 + T cells stimulated with antigen and APCs in 
the presence of  IL-4 for 1 wk gave rise to Th2 cells since 
supematants obtained 48 h after stimulation contained IL-4 
but not IFN-~/, as detectable by immunoassay (Figs. 1 A and 
2 C). Flow cytometric analysis of  these Th2 populations 
showed that they consisted predominantly of  IL-4--produc- 
ing cells (>50%) (Figs. 1 B and 2 A). A small percentage 
(4%) of  the cells still synthesized IFN-~/, showing that the 
population was actually heterogeneous, although this cy- 
tokine was not detectable in the supernatants (Figs. 1 A and 
2 C). Although the flow cytometric analysis of  these Th2 
populations uggested that "-~40% of the cells did not pro- 
duce IL-4, this may be explained by our previous observa- 
tions, where we have shown that IL-4 synthesis is relatively 
transient in Th2 clones (35). This transient production of  
IL-4 protein correlates with transient expression of  IL-4 
mRNA (50). Since the cells are not synchronously in cell 
cycle (35), or possibly not synchronously secreting IL-4, 
and since IL-4 production is short-rived, it is unlikely that 
it will be possible to observe 100% of cells within a Th2 
population producing this cytokine simultaneously (35). It 
is also possible that some of these cells staining negative for 
IFN-~/ or IL-4 synthesis represent undifferentiated precur- 
sors, which do not produce these cytokines, or produce low 
levels of  IFN-~/and IL-4, which are below the level of  de- 
tectahility. Th2 populations also developed (11% produc- 
ing IL-4 only), although to a lesser extent, upon stimula- 
tion with antigen and APCs alone, reflecting endogenous 
IL-4 in the cultures (35; Figs. 1 B and 2 A). 
We tested the ability of  Th2 populations to be converted 
to a Th l  phenotype after 1 wk of  stimulation in the pres- 
ence of  IL-4 (Figs. 1 and 2), by restimulation with antigen 
for 1 wk (Fig. 1 C) or weekly for 3 wk (Fig. 2 B) under 
conditions designed to reverse the phenotype. Restimula- 
tion of  Th2 cells for 1 wk in the presence of lL-12 and anti- 
IL-4 mAbs initiated a change in phenotype as seen by im- 
Figure 1. Keversal of cytokine profiles in 
early Thl and Th2 populations. LECAM- 
1 b~igh~, CD4 + T cells from TCR-ot/13 
DOl1.10 transgenic mice were first stimu- 
lated for 1 wk with splenic APCs and OVA, 
in either medium alone, with IL-4, or IL-12 
plus or minus anti-IL-4, asdescribed inMa- 
terials and Methods. Cells were harvested 
and a portion of them restimulated for anal- 
ysis of supernatants for IFN-3 t and IL-4 by 
immunoassay (A), or of cells by flow cy- 
tometry (B and C), as described, to deter- 
mine their Th phenotype. Frequencies of
IFN-'y--producing cells are shown on the 
y-axis and IL-4--producing cells on the x-axis. 
After 1 wk of antigenic stimulation (as 
above) the remaining CD4 + T ceils (100% 
KJ1-26 +) propagated from each group were 
washed and resdmulated under conditions 
designed to achieve phenotype reversal (and 
controls), for 1 wk as described inMaterials 
and Methods, and supematants were ana- 
lyzed by immunoassay or ceils were analyzed 
by flow cytometry for IFN-~/and IL-4 pro  
duction, as above, after appropriate r stimu- 
lafion. 
munoassay (Fig. 1 A). Analysis at the single cell level showed 
the emergence of  a distinct population of  Thl  cells produc- 
ing IFN-~/only (12%) (Fig. 1 C). The frequency of  IL-4-- 
producing cells in Th2 populations restimulated with IL-12 
and anti-IL-4 was only slightly diminished (51-39%), whereas 
restimulation i  the presence of  exogenous IL-4 enhanced 
their frequency (51-79%; Fig. 1 C). Distinct populations of  
IFN-~/-producing cells also appeared when Th2 popula- 
tions were restimulated repeatedly (for 3 wk) in IL-12 plus 
anti-IL-4 (Fig. 2 B). In this case, an enhanced frequency of  
Thl  cells producing IFN-~/ (>25%), as well as Th0 cells 
(51-53) producing both IL-4 and IFN-% were seen (7%) 
(Fig. 2 B). This apparent change from a Th2 to a Thl  phe- 
notype was also observed upon immunoassay of  super- 
natants from these Th cell populations upon restimulation 
(Fig. 2 C). These Th2 cells, although very similar in their 
cytokine profile as measured by immunoassay, are poten- 
tially different from those of  Szabo et al. (34), since in the 
present study, endogenous IL-12 was not neutralized ur- 
ing primary stimulation. 
We also examined the stability of  Thl  populations de- 
rived from stimulation for 1 wk with antigen and APCs in 
the presence of  IL-12 plus anti-IL-4 mAbs, which pro- 
duced high levels of lFN-~/and undetectable IL-4 upon re- 
stimulation (Figs. 1 A and 2 C). In agreement with is, 
flow cytometric analysis of  the cells within this population 
showed that they produced excusively IFN-~/(>80%) and 
no IL-4 (Figs. 1 B and 2 A), upon restimulation with PMA 
and ionomycin. Approximately 20% of cells stained nega- 
tive for IFN-~/ and IL-4 production, suggesting that they 
may be undifferentiated precursors producing neither cy- 
tokine. Alternatively, these cells could be producing low 
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levels of either cytokine undetectable by the methods used. 
Restimulation of these strongly polarized Thl  cells with 
antigen for 1 wk in the presence of IL-4 diminished the 
IFN-7 levels and enhanced IL-4 levels in the supernatants 
(Fig. 1 A). Single cell analysis revealed a small number of 
Th2 cells excusively producing IL-4 (8%, Fig. 1 C). How- 
ever, repeated stimulation of the Thl  cells for 3 wk in the 
presence of IL-4 (Fig. 2 B) generated larger frequencies of 
cells producing IL-4 (38-41%). This was accompanied by 
increased levels of IL-4 in the supernatants (Fig. 2 C), sug- 
gesting that outgrowth was required to achieve the switch. 
The changes in the cytokine profiles of both Thl  and Th2 
populations were only seen if the conditions required to 
achieve phenotype reversal were applied during antigenic 
stimulation, and this was often accompanied by dramatic 
cell death in the cultures (data not shown). 
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Figure 2. Reversal of phenotype in early 
Thl and Th2 populations is more marked 
after epeated stimulation i  oppositely po- 
larizing stimuli. Cells were treated and ana- 
lyzed as in Fig. 1, except that after the initial 
1 wk of stimulation, the cultures were re- 
peatedly stimulated for 3 wk in oppositely 
polarizing stimuli, to reverse the Th pheno- 
type (and controls) as above. The various 
populations were analyzed as described in
Fig. 1 after stimulation i PMA and iono- 
mycin, for IFN-7 and IL-4 production by 
immunoassay or flow cytometry. 
The most dramatic observation, however, was the ability 
of added IL-4 to significantly diminish the frequency of 
Thl  cells producing IFN-~/(81-10%, Figs. 1 and 2) after as 
little as 1 wk of restimulation (Fig. 1 C). This was also re- 
flected by the decreased levels of IFN-~ detectable in the 
supernatants of the same cells by ELISA (Figs. 1 A and 2 
C). In contrast, the frequencies of IL-4-producing cells in 
polarized populations of Th2 cells remained relatively stable 
even when repeatedly stimulated in the presence of IL-12 
plus anti-IL-4 mAbs (51-40%, Fig. 2 B). 
Thus, although IL-4 and IFN-~/cytokine profiles in the 
supematants of stimulated early Thl  and Th2 populations 
indicated commitment of naive cells towards a strongly po- 
larized Th2 or Thl  phenotype, further stimulation in op= 
positely polarizing conditions converted the cytokine pro- 
file of these populations (Figs. 1 A and 2 C). However, 
such analysis of cytokines in the supernatants gives no in- 
formation on the identity of the cells within the popula- 
tion, or the level of heterogeneity or commitment for cy- 
tokine production at the single cell level. Furthermore, 
immunoassays are limiting since they cannot determine the 
presence of cells producing both IFN-~/and IL-4 simulta- 
neously, or cells producing neither of these cytokines. It is 
possible that not all the IFN-~/- or IL-4-producing cells 
within the early Thl  or Th2 populations are fully commit- 
ted after a primary stimulation with antigen, but rather e- 
tain their ability to respond to signals in their environment 
(see Fig. 6 A). The flow cytometric analysis of single cells 
producing IFN-~/and IL-4 shows that early Thl  and Th2 
populations are heterogeneous. Taken together, our studies 
suggest hat an apparent reversal of phenotype may reflect 
clonal outgrowth of a combination of a small number of 
contaminating Th cells of the opposite phenotype, and dif- 
ferentiating uncommitted precursors, rather than dediffer- 
entiation of Thl  or Th2 cells. 
Th I and Th2 Populations Generated by Chronic Stimulation 
with Antigen in the Presence of Polarizing Stimuli Are Irrevers- 
ible. Thl and Th2 clones have been generally selected 
from polarized T cell populations derived from hyperim- 
munized mice, or from mice or humans suffering from 
chronic infectious disease or allergy (1-4). It has been diffi- 
cult to reverse the phenotype of such chronic Thl  or Th2 
responses in vivo (20, 21, 25-27, 54--56). To simulate po- 
larized Th cell populations i olated in chronic disease, we 
repeatedly stimulated naive CD4 + T cells under polarizing 
conditions and then assessed the heterogeneity and plastic- 
ity of cytokine-producing cells at the single cell level. 
CD4 + T cells from TCR-ot/f3 DOl1.10 transgenic ani- 
mals, stimulated with splenic APCs and OVA for 3 wk in 
medium alone or in the presence of IL-4, showed a shghtly 
more dominant Th2 phenotype (>66% cells producing IL-4 
only; Fig. 3 A) than Th2 populations arising after 1 wk of 
stimulation in IL-4 (Figs. 1 B and 2 A). This was reflected 
by higher levels of IL-4 in the supernatants of these polar- 
ized populations upon restimulation (Fig. 3 C). These 
chronically derived Th2 populations remained relatively 
stable, even upon repeated restimulation under conditions 
designed to reverse their cytokine profile, with only the 
emergence ofsmall subpopulations (<4%) expressing either 
IFN-% or IFN-',/and IL-4 (Fig. 3 B). 
Highly polarized Thl cells developed from repeated stim- 
ulation of naive CD4 + T cells for 3 wk with antigen and 
APCs, in the presence of IL-12 and anti-IL-4 (92% pro- 
duced IFN-31 only; Fig. 3 A). These Thl populations could 
not be redirected towards aTh2 phenotype by repeated re- 
stimulation i  the presence of IL-4 (Fig. 3 B), in contrast to 
the polarized Thl populations arising after 1 wk of stimulation 
under the same conditions (Figs. 1 C and 2 B). Again, the 
single cell analysis of IFN-~- and IL-4-.producing cells was 
in keeping with, although again more informative than, 
standard immunoassay of these cytokines in the supematants 
of stimulated Thl cells (Fig. 3 C). Such resistance to a reversal 
in their cytokine profile is likely to be due to increased 
commitment and homogeneity among IL-4-- or IFN-'y- 
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producing cells with time, as well as decreased numbers of 
precursors, ince there is no further source of naive or un- 
committed cells in the cultures (see model in Fig. 6 B). 
Thl and Th2 populations arising after chronic stimula- 
tion of CD4 + T cells in the presence of polarizing condi- 
tions greatly resembled those populations arising after short- 
term stimulation, with a few subtle differences (Figs. 1-3). 
First, the number of IL-4-producing cells within the Th2 
population was slightly increased after repeated stimulation 
in IL-4 (from 51% after 1 wk, to 66% after 3 wk). This was 
also the case for the IFN-'y-producing cell number within 
the Thl  population (from 81% after 1 wk, to 92% after 3 
wk). In both situations this was accompanied by a slight de- 
crease in the number of double negative cells producing 
neither IFN-'y nor IL-4, which could have resulted from 
their differentiation to IFN-~/- or IL-4-producing cells, or 
from a lack of survival in the cultures. In addition, in short- 
term cultures, small percentages of contaminating Th cells 
of the opposite phenotype were sometimes detectable by 
flow cytometry (Figs. 1 and 2), although not always by im- 
munoassay (Figs. 1 A and 2 C), and these contaminants of- 
ten decreased with repeated stimulation in a polarizing 
stimulus (Fig. 3 A). These subtle differences in the Th 1 and 
Th2 populations arising after 1 wk of stimulation, as com- 
pared to those arising from repeated antigenic stimulation 
in the polarizing stimuh, may account for differences in 
their level of commitment for production oflFN-',/or IL-4. 
It is interesting to note that repeated stimulation of 
CD4 + T cells with IL-12, in the absence ofanti-IL-4 mAbs 
(Fig. 3 A) resulted in the development of large percentages 
of Th0 cells that produced both IFN-~/ and IL-4. This 
population undoubtedly resulted from repeated stimulation 
in the presence of endogenous IL-4 and IL-12, and ap- 
peared to be relatively unstable, disappearing when there 
was an alteration in the ratio of IL-4 to IL-12 in the cul- 
tures. Whether polarized populations of Thl  and Th2 cells 
differentiate via an intermediate population producing both 
IFN-~ and IL-4, as previously proposed, isstill unclear (57). 
When naive CD4 + T cells were stimulated repeatedly in
IL-12 alone, a dominant Thl  population emerged, how- 
ever, these populations also gave rise to 9% of cells produc- 
ing IL-4 alone, or 5% IFN-~/and IL-4 simultaneously (Fig. 
3 A). The increase in IL-4 single positives as well as the IL-4 
plus IFN-~ double positives (Fig. 3 A) in the 3- versus 1-wk 
stimulation (Figs. 1 B and 2 A) may be due to increasing 
amounts of endogenous levels of IL-4 produced upon re- 
peated stimulation. This is supported by the lack of IL-4- 
producing cells and dominant Thl phenotype which 
emerges from cultures repeatedly stimulated in the pres- 
ence of IL-12 and anti-IL-4 (Fig. 3 A). Thl  populations 
derived from 3-wk stimulations in the presence of IL-12 
showed no dramatic decrease in IFN-~/-producing cells, al- 
though the brightness of the stain was diminished, when 
repeatedly stimulated in the presence of IL-4. However, 
anti-IL-4 plus IL-12 markedly increased the frequencies of 
IFN-~/-producing cells (Fig. 3 B). In addition, cells simul- 
taneously producing IFN-~ and IL-4 appeared to be rela- 
tively unstable (Fig. 3, A and B). 
Thl and Th2 Population Reversibility IsLost after Long-term Stimulation 
Although the Th l  and Th2 populations arising from 
chronically stimulated CD4 + T cells were resistant to re- 
version ofphenotype, cultures of polarized Th l  populations 
restimulated in the presence of IL-4 showed a marked de- 
crease in IFN-~/-producing cells (Fig. 3 B; 92-46%), as 
with the data obtained with uncommitted Th l  popula- 
tions, presented in Figs. 1 and 2. In contrast, the frequen- 
cies of IL-4-producing cells in polarized Th2 populations 
did not decrease significantly in the presence of IL-12 and 
anti-IL-4 (Fig. 3 B), nor increase significantly in the pres- 
ence of exogenous IL-4. 
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Figure 3. Long-term Thl 
and Th2 populations are irre- 
versible. Th effector populations 
were derived as described inMa- 
terials and Methods (Fig. 1), ex- 
cept that in this case, cultures 
from naive CD4 + T cells were 
stimulated weekly for 3 wk with 
splenic APCs and OVA in the 
culture conditions described in 
Fig. 1. A portion of the cells 
were harvested after 3 wk, re- 
stimulated with PMA and iono- 
mycin, and analyzed for IFN-'I 
and IL-4 production by immu- 
noassay and by flow cytometry as
above (Fig. 1) The remaining 
CD4 + T cells (100% KJ126 +) 
were washed and restimulated 
weekly for 3 wk at 2.5 • 10s/ 
well with irradiated splenic 
APCs plus OVA in culture con- 
ditions designed to reverse the 
phenotype (and controls) as de- 
scribed above (Fig. 1). Cells were 
then restimulated with PMA and 
ionomycin, and IFN-'y and IL-4 
production was assessed by im- 
munoassay nd by flow cytome- 
try as above. 
In summary, Th l  and Th2 populations arising after 1 wk 
of stimulation, although apparently strongly polarized, are 
still heterogeneous with respect o differentiation a d com- 
mitment, possibly as a result of cytokine receptor expres- 
sion or the engagement of a particular signaling pathway 
(34). It is likely that repeated stimulation results in a higher 
degree of homogeneity and renders the population more 
resistant to change. It is interesting to note that although 
highly committed Th populations do not appear to acquire 
the ability to produce cytokines of the opposite Th profile, 
Th l  cells may be induced to lose their capacity to produce 
[FN-% In contrast, IL-4-producing cells appear more re- 
sistant o the effects of  IL-12 and anti-IL-4 mAbs, perhaps 
reflecting rapid loss of  IL-12 receptors for Th l  induction 
(34). It is possible that this may be specific for the BALB/c 
genetic background on which this TCK-ix/I3 transgenic 
mouse was made, since we have reported that mice on this 
background have a "defect" inasmuch as they default o the 
Th2 pathway under neutral conditions during secondary 
stimulation. However, our data may explain previous sug- 
gestions that it is possible to,reverse the phenotype of early 
Thl  T cells by addition of  IL-4, but not of  early Th2 cells 
by addition of  IL-12 (31, 33, 34). Thus the reported appar- 
ent reversal of  a Th l -  to a Th2-type phenotype may result 
from the disappearance of IFN-~/-producing cells in com- 
bination with differentiation and/or clonal outgrowth of  
Th2 cells. This reversal is more difficult to achieve in Th2 
cells, since IL-4--producing cells appear to be much more 
resistant to downmodulation (33, 34). 
Th l and Th2 Clones Have an Irreversible Phenotype: IL-4 
Reduces the Frequency of lFN- y--produdng Cells by Th l Clones 
Resulting in Marked Inhibition of lFN- y Secretion. To assess 
whether the IL-4-induced reduction in IFN-~/production 
by long-term Thl  populations reflected apopulation of  still 
uncommitted cells, a panel of  antigen-specific clones de- 
rived from single cells were selected from hyperimmunized 
mice. These clones, which represent a completely differen- 
tiated population, were tested similarly by stimulation in 
the presence of  oppositely polarizing stimuli (Figs. 4 and 5). 
As expected, resting Thl  and Th2 clones repeatedly stimu- 
lated with antigen, in the presence of oppositely polarizing 
stimuli, did not reverse their cytokine profile, indicating a 
committed phenotype. However, repeated antigenic stim- 
ulation of  the Thl  clones in the presence of  IL-4 again re- 
sulted in a significant reduction of  IFN-~/-producing cells 
or a diminishment in their brightness of  staining (Fig. 4), as 
shown by FACS | analysis, and more dearly decreased lev- 
els of  IFN-~/ in supematants as detected by immunoassay 
(Fig. 5). Conversely, addition of  IL-12 plus (or minus, not 
shown) anti-IL-4 mAbs resulted in increased percentages of
Thl  cells staining brightly for IFN-~/(Fig. 4), which corre- 
lated with increased levels of  IFN-~/ in the supernatants 
(Fig. 5). IL-4's effects were only seen by immunoassay in
chronic stimulations, since in the short term, this cytokine 
either shows no effect or actually enhances IFN-~/secretion 
by acting as a growth or viability factor for Th l  clones (7, 
and Murphy, E., and A. O'Garra, unpublished observations). 
Again, little effect was observed on IL-4-producing cells in 
Th2 clones after repeated stimulation in the presence of 
anti-IL-4 (not shown) or IL-12 and anti-IL-4 mAbs (Fig. 
4). The mechanism oflL-4's ability to downregulate IFN-~ ~- 
producing cells in differentiated Thl  cells is unclear at this 
stage. It is possible that IL-4 mediates its effects on Thl  
clones by downregulating endogenous levels of  IL-12 pro- 
duced by splenic APCs. However, it is important o note 
Thl  
Th2 
A Primary Stimulation of 
Th Clones (1 week) 
B Restimulation of Th Clones 
(3 weeks) 
h 
Medium Alone IL-4 
a 
101, - " "" 
d I ":t 5~ '40"~ 
,o3. I e ,.0,3,.0] 
IFNy ~/ lO11L .4  lOa 101 " 1~ 
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'., ~.:.. 
9 7.0 I~o I I Ih~- ; ]~ 
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59.0 140.0 ,S6.0 134.0 
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Figure 4. Cytokine phenotype of 
Thl and Th2 clones is irreversible: 
IL-4 downmodulates IFN-'?-producing 
cells. Long-term established Thl clones 
HDK1 (a) and HDK-2 (c) (KLH spe- 
cific, I-A a restricted), and Th2 clones, 
CDC25 (e) (rabbit Ig specific, C3D2/ 
F1); or short-term Thl (b) and Th2 (d) 
clones (CD4 § OVA-specific T cells de- 
rived from single cell cultures from 
DO10 TCR-ot/~ transgenic mice; 35) 
were tested for their ability to retain 
their respective phenotypes. Resting T 
cell clones (2 X 105/well) were first 
stimulated with PMA and ionomycin 
and analyzed for intraceUular IFN-~ and 
IL-4 as above (Fig. 1 A) to assess their 
basal state (.4). T cell clones were then 
tested for their ability to retain their re- 
spective phenotype when stimulated 
weekly for 3 wk with antigen (KLH, 
100 ~g/ml; rabbit Ig, 500 I~g/ml; 
OVA-peptide, 0.3 ~M) and irradiated 
splenic APCs (3,000 tad) in the presence 
of IL-2 (100 U/ml) alone, or in combi- 
nation with IL-4 (20 ng/ml), or IL-12 
(10 U/ml) plus anti-IL-4 (10 p.g/ml). 
Resulting populations were restimulated 
with PMA and ionomycin and analyzed 
for intracellular cytokine synthesis as 
above (B). 
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Figure 5. IL-4 significantly downregulates IFN-~/production by Thl clones. Th clones were treated essentially asin Fig. 4, except that the final re- 
stimulation with PMA and ionomycin was for 48 h, after which supernatants were collected for immunoassay of IFN-'y and IL-4 production. 
that this effect of  IL-4 on IFN-~/production added during 
repeated antigenic stimulation is still observed upon imme- 
diate restimulation of  the cells with PMA and ionomycin, 
in the absence o f lL -4  and the splenic APCs. 
These findings may explain previous data demonstrating 
a reduction in IFN=~/levels by IL-4 during a delayed-type 
hypersensitivity response to L. major in vivo (11). Thus, in an 
in vivo setting, where undoubtedly a heterogeneous popu- 
lation exists, despite the dominant function of  extremely 
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polarized clones obtained from individuals during certain 
infectious diseases (54, 58-64), or autoimmune pathologies 
(12, 14, 65-68), the disappearance of IFN-~/-producing 
cells could suggest an absolute change from a Th l  to a Th2 
phenotype. 
Implications for Immunotherapy in Chronic Diseases Ari ing 
from Infection, Allergy, or T Cell-mediated Autoimmunity. 
These studies may provide new approaches for therapeutic 
intervention during chronic disease. It is likely that even 
+ 
O 
Reversible 
IFN'~{++ ~ IL'4++ 
Uncommited Precursors (IL-2) 
Th0 cells (IFN-7+: 1L-4 +) 
'rr=ble 
I Uncommited Precursors (IL-2) 
Th0 cells (IFN-T+: IL-4 +) 
Reversible 
IrN-~ ++++ Th l  ~ Th2 IL-4 ++++ 
Uncommited Precursors (IL-2) 
Th0 cells (IFN-~': IL-4 +) 
Naive CD4 + T cells (IL-2) 
Recently Emerging Thymocytes 
during chronic disease, manifested by high levels of  Th l -  
or Th2-type cytokines, that the population of CD4 + T 
cells in a draining lymph node consists of  a spectrum of  Th 
cells at different stages of  differentiation (Fig. 6 C). Im- 
mune regulation in vivo will most likely restrict the fre- 
quency of  completely differentiated and polarized Th l  and 
Th2 clones within the population. However, these cells may 
play an important role in determining the extent of  pathol- 
ogy, by their production of  high levels of  cytokines. Our  
data suggest that it may be possible to override the control- 
ling influence of  such clones producing extreme levels of  
cytokines. For example, the administration of  antigen to- 
gether with the polarizing conditions will enhance a change 
in Th phenotype by the recruitment of  naive and/or  un- 
committed cells, which will undoubtedly be present even 
Figure 6. Model for reversal of Th phenotypes. The 
model for heterogeneity ofTh phenotypes and their rever- 
sal is based on: (A and B) data obtained from flow cyto- 
metric analysis of intraceUular cytokine synthesis in polar- 
ized Thl and Th2 populations obtained from TCIt.-~/13 
transgenic CD4 + T cells stimulated in vitro with APCs 
plus OVA in the presence of IL-12 plus anti-IL-4 mAbs 
(Thl) or IL-4 (Th2) for (A) 1 wk or (B) 3 wk, as in Figs. 
1-3. (C) The prediction of the heterogeneity of Th phe- 
notypes and their reversal during an immune response in
vivo. 
during chronic disease. These cells, by differentiation and 
clonal outgrowth, will suppress the dominant Th phenotype 
as modeled from our flow cytometric analysis of IFN-~/- and 
IL-4-producing cells in the in vitro reversal of  polarized 
Th cell populations. The ability of  IL-4 to downregulate 
IFN-~/-producing cells may indicate that it may be more 
possible to dampen or revert inflammatory or Th l -med i -  
ated pathologies, than atopic or chronic Th2-dominated 
diseases, since IL-4--producing cells were more resistant to 
change. In these situations it may be necessary to reduce 
the ongoing immune response as well as to restimulate the 
populations in the presence of lL -12 plus anti-IL-4 in order 
to outnumber and suppress dominant clones of  a Th2 phe- 
notype. 
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